BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Dennis BB, Naji L, Jajarmi Y, Ahmed A, Kim D. New hope for hepatitis C virus: Summary of global epidemiologic changes and novel innovations over 20 years. World J Gastroenterol 2021; 27(29): 4818-4830 [PMID: 34447228 DOI: 10.3748/wjg.v27.i29.4818]
URL: https://www.wjgnet.com/1948-5182/full/v27/i29/4818.htm
Number Citing Articles
1
Michelle G. Brown, John F. Lindo, Ivan E. Vickers, Kereann Nelson, Yakima Phillips, Cameil Wilson-Clarke, Samuel Gavi, Gene D. Morse, Andrew H. Talal. Seroprevalence and Genotype Diversity of Hepatitis C Virus in the Caribbean—A ReviewTropical Medicine and Infectious Disease 2023; 8(7): 370 doi: 10.3390/tropicalmed8070370
2
Calvin Q Pan, Andrew J Park, James S Park. New perspectives in hepatocellular carcinoma surveillance after hepatitis C virus eradicationGastroenterology Report 2023; 12 doi: 10.1093/gastro/goae085
3
Rocio Nunez-Torres, Guillermo Pita, María Peña-Chilet, Daniel López-López, Jorge Zamora, Gema Roldán, Belén Herráez, Nuria Álvarez, María Rosario Alonso, Joaquín Dopazo, Anna Gonzalez-Neira. A Comprehensive Analysis of 21 Actionable Pharmacogenes in the Spanish Population: From Genetic Characterisation to Clinical ImpactPharmaceutics 2023; 15(4): 1286 doi: 10.3390/pharmaceutics15041286
4
Brittany B. Dennis, Glenda Babe, Anastasia Gayowsky, Tea Rosic, Myanca Rodrigues, Paxton Bach, Richard Perez, Claire de Oliveira, Jeffrey Samet, Victoria Weaver, Samantha Young, Joanna Dionne, Aijaz Ahmed, Donghee Kim, Lehana Thabane, Zainab Samaan. Health service utilization, substance use treatment response, and death in patients with opioid use disorder and comorbid hepatitis C findings from prospective cohort study with administrative database linkageJournal of Substance Use and Addiction Treatment 2024; 167: 209524 doi: 10.1016/j.josat.2024.209524
5
Richie Manikat, Aijaz Ahmed, Donghee Kim. Current epidemiology of chronic liver diseaseGastroenterology Report 2023; 12 doi: 10.1093/gastro/goae069
6
Arwa Mohammed Othman, Asma’a Ahmed Al-hnhna, Belques Sharaf Al-Huraibi, Rowa Mohammed Assayaghi, Talal Yahya Al-Qahtani, Kamal Hamoud Jahzar, Marwan Mohammed Al-Huthaifi. Prevalence of hepatitis C virus among patients with arthralgia: is it logic for screening?Virology Journal 2023; 20(1) doi: 10.1186/s12985-023-02124-w
7
A. I. Gubenko, D. V. Goryachev, A. I. Muravieva, G. V. Shukshina. Planning a clinical trial programme for direct-acting antivirals for chronic viral hepatitis CBulletin of the Scientific Centre for Expert Evaluation of Medicinal Products. Regulatory Research and Medicine Evaluation 2023; 13(4): 519 doi: 10.30895/1991-2919-2023-499
8
Laura Cardoso Corrêa-Dias, Ágata Lopes-Ribeiro, Geovane Marques-Ferreira, Letícia Gomes-de-Pontes, Thaiza Aline Pereira-Santos, Erik Vinicius de Sousa Reis, Thaís de Fátima Silva Moraes, Olindo Assis Martins-Filho, Edel Figueiredo Barbosa-Stancioli, Flávio Guimarães da Fonseca, Jordana Grazziela Coelho-dos-Reis. HCV immunodominant peptide mapping reveals unique HLA-A*02-restricted signatures: insights for CD8+ T-cell-based vaccines and immunotherapiesImmunogenetics 2025; 77(1) doi: 10.1007/s00251-025-01370-2
9
Simone Kresevic, Mauro Giuffrè, Milos Ajcevic, Lory Saveria Crocè, Agostino Accardo. 9th European Medical and Biological Engineering ConferenceIFMBE Proceedings 2024; 113: 202 doi: 10.1007/978-3-031-61628-0_22
10
Muhammad Radzi Abu Hassan, Huan-Keat Chan, Mahani Nordin, Ranimah Yahya, Wan Ruzilasalwa Wan Sulaiman, Siti Aminah Akbar Merican, Darisah Lah, Xiaohui Sem, Sonjelle Shilton. Assessing feasibility of a modified same-day test-and-treat model for hepatitis C among rural people who inject drugsHarm Reduction Journal 2023; 20(1) doi: 10.1186/s12954-023-00780-3
11
Berin Karaman Mayack, Muhammed Moyasar Alayoubi, Hakan Mikail Gezginci. In silico design of potential HCV NS5B inhibitors: a comprehensive approach combining combinatorial library generation, ensemble docking, MM-GBSA calculations, QSAR model development, and molecular dynamicsJournal of Research in Pharmacy 2025; 29(2): 871 doi: 10.12991/jrespharm.1634330
12
Shelley N. Facente, Rachel Grinstein, Roberta Bruhn, Zhanna Kaidarova, Erin Wilson, Jennifer Hecht, Katie Burk, Eduard Grebe, Meghan D. Morris, Pierre Roques. Hepatitis C prevalence and key population size estimate updates in San Francisco: 2015 to 2019PLOS ONE 2022; 17(5): e0267902 doi: 10.1371/journal.pone.0267902
13
Ghirmay Ghebrekidan Ghebremeskel, Michael Berhe Solomon, Oliver Okoth Achila, Samuel Tekle Mengistu, Rahel Frezghi Asmelash, Araia Berhane Mesfin, Mohammed Elfatih Hamida. Real-world treatment outcome of direct-acting antivirals and patient survival rates in chronic hepatitis C virus infection in EritreaScientific Reports 2023; 13(1) doi: 10.1038/s41598-023-47258-7
14
Ruiyuan Yang, Kexin Li, Cailun Zou, Aileen Wee, Jimin Liu, Liwei Liu, Min Li, Ting Wu, Yu Wang, Zikun Ma, Yan Wang, Jingyi Liu, Ang Huang, Ying Sun, Binxia Chang, Qingsheng Liang, Jidong Jia, Zhengsheng Zou, Xinyan Zhao. Alanine Aminotransferase and Bilirubin Dynamic Evolution Pattern as a Novel Model for the Prediction of Acute Liver Failure in Drug-Induced Liver InjuryFrontiers in Pharmacology 2022; 13 doi: 10.3389/fphar.2022.934467